HCS
ARKG icon

Himension Capital (Singapore)’s ARK Genomic Revolution ETF ARKG Stock Holding History

Himension Capital (Singapore)’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Sell
47,698
-37,466
-44% -$1.19M 0.12% 65
2026
Q1 		$2.25M Buy
+85,164
New +$2.49M 0.17% 46

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Himension Capital (Singapore)'s ARKG Position: Q2 2026 in Review

Himension Capital (Singapore) reduced its ARK Genomic Revolution ETF (ARKG) stake by 44% in Q2 2026, selling an estimated $1.19M and leaving 47,698 shares worth $2.01M. The position accounts for 0.12% of the portfolio, ranked #65.

Himension Capital (Singapore) first reported a position in ARKG in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.25M in Q1 2026. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Himension Capital (Singapore) held 47,698 shares of ARK Genomic Revolution ETF worth $2.01M as of Q2 2026.
  • Himension Capital (Singapore) sold 37,466 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.19M.
  • ARK Genomic Revolution ETF made up 0.12% of Himension Capital (Singapore)'s portfolio in Q2 2026, its #65 holding.
  • Himension Capital (Singapore) first reported a position in ARK Genomic Revolution ETF in Q1 2026 and has held it in 2 quarters since.
  • Himension Capital (Singapore)'s ARK Genomic Revolution ETF position peaked at $2.25M in Q1 2026.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Himension Capital (Singapore)'s 13F filing for Q2 2026, filed 13 Aug 2026.